In HUVEC experiments, colivelin treatment decreased cell viability.
In plain wordsIn cells, colivelin treatment decreased cell viability.
- Peptide
- Colivelin
- Outcome
- DecreaseCell viability
- Study
humann: not reported in source
ox-LDL-treated HUVECs- Outcome group
- Cell viability and death · Cardiovascular
Source sentences
Both Mdivi-1 and colivelin treatments resulted in decreased cell viability and increased cellular senescence
2 context sentences(design, population, supporting numbers)
Human umbilical vein endothelial cells (HUVECs) were treated with oxidized low-density lipoprotein (ox-LDL) to mimic AS, and the effects of dendrobine on cell viability, lipid deposition, mitochondrial function, and cellular senescence were evaluated.
Subsequently, cells were treated with the mitophagy inhibitor Mdivi-1 and the STAT3 agonist colivelin to assess the role of mitophagy and STAT3 signaling in dendrobine regulation.
In this study, Colivelin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Colivelin.